Seagen Inc.
Humanized antibodies to LIV-1 and use of same to treat cancer
Last updated:
Abstract:
The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
Status:
Grant
Type:
Utility
Filling date:
4 Jan 2018
Issue date:
8 Mar 2022